P1.21. Potential Role of Serum Glycoproteomics in Predicting irAEs in NSCLC Patients Treated with Immunotherapy - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Young Kwang Chae
Meta Tag
Speaker Young Kwang Chae
Topic Pathology & Biomarkers: Biomarkers for Immuno-oncology
serum glycoproteomics
immune-related adverse events
non-small cell lung cancer
pretreatment blood samples
immune checkpoint inhibitor
liquid chromatography
mass spectrometry
artificial intelligence-based data processing engine
glycopeptides signature
Powered By